Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Hamilton

Showing results (11-20 of 279) with videos related to

Pageof 28
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 16, 2017
New research in testicular cancer, ASCO-GU 2017Robert J Hamilton, Christian Kollmansberger
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 15, 2019
Another dimension to the understanding of local therapy for metastatic prostate cancerMichael Leveridge, Robert J Hamilton
Andrology|November 14, 2022
miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-upJulian Chavarriaga, Robert J Hamilton
Current Opinion in Supportive and Palliative Care|June 8, 2017
Novel imaging in advanced prostate cancerHanan Goldberg, Robert J Hamilton
Advances in Urology|April 20, 2018
Dissecting the Evolving Risk of Relapse over Time in Surveillance for Testicular CancerMadhur Nayan, Robert J Hamilton
European Urology|November 19, 2016
Reply from Authors re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer is Safe and Will Remain Unchanged. Eur Urol 2017;71:130-131Madhur Nayan, Robert J Hamilton
The Canadian Journal of Urology|July 5, 2006
The impact of introducing laparoscopic radical prostatectomy on surgical wait times for prostate cancerRobert J Hamilton, Antonio Finelli
The Urologic Clinics of North America|July 7, 2019
The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis CancerZachary Klaassen, Robert J Hamilton
BMC Medicine|September 17, 2011
5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Robert J Hamilton, Stephen J Freedland
Epidemiology (Cambridge, Mass.)|February 16, 2007
Statins and cancer risk: what do we know and where do we go from here?Patricia G Moorman, Robert J Hamilton
Pageof 28

Showing results (11-20 of 279) with videos related to

Sort By:
Pageof 28
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 16, 2017
New research in testicular cancer, ASCO-GU 2017Robert J Hamilton, Christian Kollmansberger
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 15, 2019
Another dimension to the understanding of local therapy for metastatic prostate cancerMichael Leveridge, Robert J Hamilton
Andrology|November 14, 2022
miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-upJulian Chavarriaga, Robert J Hamilton
Current Opinion in Supportive and Palliative Care|June 8, 2017
Novel imaging in advanced prostate cancerHanan Goldberg, Robert J Hamilton
Advances in Urology|April 20, 2018
Dissecting the Evolving Risk of Relapse over Time in Surveillance for Testicular CancerMadhur Nayan, Robert J Hamilton
European Urology|November 19, 2016
Reply from Authors re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer is Safe and Will Remain Unchanged. Eur Urol 2017;71:130-131Madhur Nayan, Robert J Hamilton
The Canadian Journal of Urology|July 5, 2006
The impact of introducing laparoscopic radical prostatectomy on surgical wait times for prostate cancerRobert J Hamilton, Antonio Finelli
The Urologic Clinics of North America|July 7, 2019
The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis CancerZachary Klaassen, Robert J Hamilton
BMC Medicine|September 17, 2011
5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Robert J Hamilton, Stephen J Freedland
Epidemiology (Cambridge, Mass.)|February 16, 2007
Statins and cancer risk: what do we know and where do we go from here?Patricia G Moorman, Robert J Hamilton
Pageof 28